Doliba Nicolai M, Qin Wei, Vatamaniuk Marko Z, Li Changhong, Zelent Dorothy, Najafi Habiba, Buettger Carol W, Collins Heather W, Carr Richard D, Magnuson Mark A, Matschinsky Franz M
Diabetes Research Center, Department of Biochemistry and Biophysics, Univ. of Pennsylvania, Philadelphia, PA 19104-6015, USA.
Am J Physiol Endocrinol Metab. 2004 May;286(5):E834-43. doi: 10.1152/ajpendo.00292.2003. Epub 2004 Jan 21.
Inhibition of ATP-sensitive K+ (K(ATP)) channels by an increase in the ATP/ADP ratio and the resultant membrane depolarization are considered essential in the process leading to insulin release (IR) from pancreatic beta-cells stimulated by glucose. It is therefore surprising that mice lacking the sulfonylurea type 1 receptor (SUR1-/-) in beta-cells remain euglycemic even though the knockout is expected to cause hypoglycemia. To complicate matters, isolated islets of SUR1-/- mice secrete little insulin in response to high glucose, which extrapolates to hyperglycemia in the intact animal. It remains thus unexplained how euglycemia is maintained. In recognition of the essential role of neural and endocrine regulation of IR, we evaluated the effects of acetylcholine (ACh) and glucagon-like peptide-1 (GLP-1) on IR and free intracellular Ca2+ concentration ([Ca2+]i) of freshly isolated or cultured islets of SUR1-/- mice and B6D2F1 controls (SUR1+/+). IBMX, a phosphodiesterase inhibitor, was also used to explore cAMP-dependent signaling in IR. Most striking, and in contrast to controls, SUR1-/-) islets are hypersensitive to ACh and IBMX, as demonstrated by a marked increase of IR even in the absence of glucose. The hypersensitivity to ACh was reproduced in control islets by depolarization with the SUR1 inhibitor glyburide. Pretreatment of perifused SUR1-/- islets with ACh or IBMX restored glucose stimulation of IR, an effect expectedly insensitive to diazoxide. The calcium channel blocker verapamil reduced but did not abolish ACh-stimulated IR, supporting a role for intracellular Ca2+ stores in stimulus-secretion coupling. The effect of ACh on IR was greatly potentiated by GLP-1 (10 nM). ACh caused a dose-dependent increase in [Ca2+]i at 0.1-1 microM or biphasic changes (an initial sharp increase in [Ca2+]i followed by a sustained phase of low [Ca2+]i) at 1-100 microM. The latter effects were observed in substrate-free medium or in the presence of 16.7 mM glucose. We conclude that SUR1 deletion depolarizes the beta-cells and markedly elevates basal [Ca2+]i. Elevated [Ca2+]i in turn sensitizes the beta-cells to the secretory effects of ACh and IBMX. Priming by the combination of high [Ca2+]i, ACh, and GLP-1 restores the defective glucose responsiveness, precluding the development of diabetes but not effectively enough to cause hyperinsulinemic hypoglycemia.
ATP/ADP比值升高对ATP敏感性钾离子(K(ATP))通道的抑制作用以及由此产生的膜去极化,被认为是葡萄糖刺激胰腺β细胞释放胰岛素(IR)过程中的关键环节。因此,令人惊讶的是,β细胞中缺乏磺脲类1型受体(SUR1-/-)的小鼠尽管基因敲除预计会导致低血糖,但仍能维持血糖正常。更复杂的是,分离的SUR1-/-小鼠胰岛对高糖刺激分泌的胰岛素很少,据此推测完整动物会出现高血糖。血糖正常是如何维持的,目前仍无法解释。鉴于神经和内分泌对胰岛素释放调节的重要作用,我们评估了乙酰胆碱(ACh)和胰高血糖素样肽-1(GLP-1)对新鲜分离或培养的SUR1-/-小鼠胰岛以及B6D2F1对照(SUR1+/+)的胰岛素释放和细胞内游离钙离子浓度([Ca2+]i)的影响。磷酸二酯酶抑制剂异丁基甲基黄嘌呤(IBMX)也被用于探究胰岛素释放中cAMP依赖的信号传导。最显著的是,与对照组相比,SUR1-/-胰岛对ACh和IBMX高度敏感,即使在无葡萄糖的情况下,胰岛素释放也显著增加。用SUR1抑制剂格列本脲使对照组胰岛去极化,可重现对ACh的高敏感性。用ACh或IBMX预处理灌注的SUR1-/-胰岛可恢复葡萄糖对胰岛素释放的刺激作用,这种作用预期对二氮嗪不敏感。钙通道阻滞剂维拉帕米可降低但不能消除ACh刺激的胰岛素释放,这支持了细胞内钙库在刺激-分泌偶联中的作用。GLP-1(10 nM)可显著增强ACh对胰岛素释放的作用。ACh在0.1 - 1 microM时可使[Ca2+]i呈剂量依赖性增加,在1 - 100 microM时可引起双相变化([Ca2+]i先急剧增加,随后是低[Ca2+]i的持续阶段)。在无底物培养基或16.7 mM葡萄糖存在的情况下均可观察到后一种效应。我们得出结论,SUR1缺失使β细胞去极化,并显著提高基础[Ca2+]i。升高的[Ca2+]i进而使β细胞对ACh和IBMX的分泌作用敏感。高[Ca2+]i、ACh和GLP-1的联合作用可恢复有缺陷的葡萄糖反应性,防止糖尿病的发生,但不足以有效导致高胰岛素血症性低血糖。